1 |
Hu X, Ge Q, Zhang Y, Li B, Cheng E, Wang Y, Huang Y. A review of the effect of exosomes from different cells on liver fibrosis. Biomed Pharmacother 2023;161:114415. [PMID: 36812711 DOI: 10.1016/j.biopha.2023.114415] [Reference Citation Analysis]
|
2 |
Zhao X, Xue X, Cui Z, Kwame Amevor F, Wan Y, Fu K, Wang C, Peng C, Li Y. microRNAs-based diagnostic and therapeutic applications in liver fibrosis. Wiley Interdiscip Rev RNA 2022;:e1773. [PMID: 36585388 DOI: 10.1002/wrna.1773] [Reference Citation Analysis]
|
3 |
Sohail AM, Khawar MB, Afzal A, Hassan A, Shahzaman S, Ali A. Multifaceted roles of extracellular RNAs in different diseases. Mil Med Res 2022;9:43. [PMID: 35948986 DOI: 10.1186/s40779-022-00405-z] [Reference Citation Analysis]
|
4 |
Fan J, Ren M, He Y. Diagnostic and Therapeutic Properties of Exosomes in Cardiac Fibrosis. Front Cell Dev Biol 2022;10:931082. [DOI: 10.3389/fcell.2022.931082] [Reference Citation Analysis]
|
5 |
Xia Y, Wang Y, Shan M, Hao Y, Liu H, Chen Q, Liang Z. Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid. Burns Trauma 2022;10:tkac025. [PMID: 35769828 DOI: 10.1093/burnst/tkac025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
6 |
Cui HS, Kim DH, Joo SY, Cho YS, Kim J, Seo CH. Exosomes derived from human hypertrophic scar fibroblasts induces smad and TAK1 signaling in normal dermal fibroblasts. Archives of Biochemistry and Biophysics 2022;722:109215. [DOI: 10.1016/j.abb.2022.109215] [Reference Citation Analysis]
|
7 |
Xie L, Zeng Y. Therapeutic Potential of Exosomes in Pulmonary Fibrosis. Front Pharmacol 2020;11:590972. [PMID: 33343360 DOI: 10.3389/fphar.2020.590972] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|